Processa Pharmaceuticals, Inc. — Director's Dealing 2021

Jun 23, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Processa Pharmaceuticals, Inc. (PCSA)
CIK: 0001533743
Period of Report: 2021-06-23

Reporting Person: Young David (Director, Chief Executive Officer, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-06-23	Common Stock	P	10000	$7.6716	Acquired	345190	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	548783	Indirect
Common Stock	689004	Indirect
Common Stock	55258	Indirect